Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021
Cancer Control · 2025
DOI: 10.1177/10732748251355841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Control, 2025. Verfasst von Rui Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Hefei Maternal and Child Health Hospital, Anhui Maternal and Child Health Care Hospital, Hefei Fifth People's Hospital,…. Hauptthemen laut MEDLINE: Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Anhui Medical University.
Abstract (Originalsprache)
Introduction
Soft Tissue and Other Extraosseous Sarcomas (STOES) represent a rare and heterogeneous group of malignancies with significant clinical challenges due to their complexity and aggressiveness. Despite their low prevalence, the global impact of STOES is substantial, necessitating a detailed examination of their epidemiology and disease burden.
Methods
This comprehensive analysis utilized data from the Global Health Data Exchange (GHDx) covering the years 1990 to 2021. We assessed the incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) for STOES, categorized by location, sex, and socio-demographic indices. Statistical methods included Estimated Annual Percentage Change (EAPC), Spearman correlation analysis, and Bayesian age-period-cohort modeling.
Findings
In 2021, STOES cases reached a global prevalence of 480,473, a significant increase from 1990. High Socio-Demographic Index (SDI) regions exhibited the highest age-standardized incidence and prevalence rates (ASIR and ASPR) at 2.05 and 10.61 per 100,000 population, respectively. Notably, significant increases were also observed in Central Asia, Central Europe, and Southern Sub-Saharan Africa. Males consistently showed higher disease rates than females. The decomposition analysis highlighted population growth and aging as primary drivers of the observed trends. Forecasting suggests a decline in the global STOES burden by 2030, though disparities will persist, particularly among males.
Conclusion
The study reveals critical geographic and demographic disparities in the burden of STOES, underscoring the ongoing higher risk among males and in certain global regions. Despite projected declines in overall disease burden by 2030, substantial disparities are expected to persist, necessitating targeted public health interventions and robust policies to effectively mitigate these differences and enhance global health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Hefei Maternal and Child Health Hospital, Anhui Maternal and Child Health Care Hospital, Hefei Fifth People's Hospital, Maternal and Child Health Care Hospital of Anhui Medical University,…
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
- Department of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
ORCID-Profile: Jialiu Fang
Förderung
- Natural Science Foundation of Anhui Medical University
Zitieren
APA
Zhu, R., Shen, Z., Zhu, H., Zhang, J., Xing, X., Wang, S., & Fang, J. (2025). Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021. Cancer Control. https://doi.org/10.1177/10732748251355841
Vancouver
Zhu R, Shen Z, Zhu H, Zhang J, Xing X, Wang S, et al. Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021. Cancer Control. 2025. doi:10.1177/10732748251355841
BibTeX
@article{Zhu2025,
author = {Zhu, Rui and Shen, Ziyuan and Zhu, Haijuan and Zhang, Jisen and Xing, Xing and Wang, Shengyou and Fang, Jialiu},
title = {Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021},
journal = {Cancer Control},
year = {2025},
doi = {10.1177/10732748251355841}
}
EUVIMED